Market Tracker

04/29 5:16pm ET

Aviragen Therapeutics Inc (NASDAQ:AVIR)

1.59
Delayed Data
As of Apr 29
 +0.0052 / +0.33%
Today’s Change
1.23
Today|||52-Week Range
2.66
-18.29%
Year-to-Date
No recent news for Aviragen Therapeutics Inc.

Today’s Trading

Previous close1.58
Today’s open1.58
Day’s range1.55 - 1.60
Volume5,064
Average volume (3 months)49,735
Market cap$61.0M
Dividend yield--
Data as of 3:56pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-54.29%
Earnings growth (this year)-29.63%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-64.19%
P/E ratioNM
Price/Sales2.98
Price/Book0.88

Competitors

 Today’s
change
Today’s
% change
AXNAoxing Pharmaceutica...-0.09-10.93%
CNATConatus Pharmaceutic...+0.02+0.70%
AKAOAchaogen Inc-0.02-0.59%
RPRXRepros Therapeutics ...-0.05-2.07%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$24.6M
Annual profit (last year)-$19.1M
Net profit margin-77.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Joseph M. Patti
Chief Financial Officer &
Executive Vice President
Mark P. Colonnese
Corporate headquarters
Alpharetta, Georgia

Forecasts